Eric Lancaster, MD, PhD

Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
Headshot of Eric Lancaster, MD, PhD
Penn Medicine Provider

About me

  • Associate Professor of Neurology at the Hospital of the University of Pennsylvania

My education and training

  • Medical School: University of Maryland School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Lancaster is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Zelikovich AS, Schneider S, Mandal AS, Hammer LH, Lancaster E. Clinical reasoning: a 72-year-old man with progressive pan-dysautonomia. , Neurology, 105(5): 2025,e213994


Eric Lancaster Autoimmune Encephalitis , Chapter in Decision Making in Adult Neurology, 2nd Edition: 2025


Lancaster E. Autoimmune Encephalitis due to CNS Synaptic Antibodies. Chapter in Encyclopedia of the Neurological Sciences. (Chapter) , Encyclopedia of the Neurological Sciences: 2025


Sharma R, Bellacicco NJ, Husar WG, Park JH, Lancaster E, Singer M. Pearls & Oy-sters: Breaking Bad CIDP: Recognition of Anti-NF155 Autoimmune Nodopathy in Refractory CIDP. , Neurology.: 2024,e209848.


Sharma R, Bellacicco NJ, Husar WG, Park JH, Lancaster E, Singer M. Pearls and Oy-sters: Breaking-bad CIDP: recognition of anti-NF155 autoimmune nodopathy in refractory CIDP , Neurology, 103(10): 2024,e209848


Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, Wei-Ting Hwang, Dan T Vogl, Adam J Waxman, Simon F Lacey, Vanessa E Gonzalez, Joseph A Fraietta, Minnal Gupta, Irina Kulikovskaya, Lifeng Tian, Fang Chen, Natalka Koterba, Robert L Bartoszek, Margaret Patchin, Rong Xu, Gabriela Plesa, Don L Siegel, Andrea Brennan, Anne Marie Nelson, Regina Ferthio, Angela Cosey, Kim-Marie Shea, Rachel Leskowitz, Megan Four, Wesley V Wilson, Fei Miao, Eric Lancaster, Beatriz M Carreno, Gerald P Linette, Elizabeth O Hexner, Regina M Young, Dexiu Bu, Keith G Mansfield, Jennifer L Brogdon, Carl H June, Michael C Milone, Edward A Stadtmauer Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy , Blood Cancer Discov, 4(2): 2023,118-133


Lancaster, E. Autoimmune Encephalitis , Chapter in Decision Making in Adult Neurology: 2023


Yoji Hoshina, Jonathan Galli, Ka-Ho Wong, Tibor Kovacsovics, Mary Steinbach, Karen L Salzman, Joseph Scott McNally, Eric Lancaster, M. Mateo Paz Soldán, and Stacey L. Clardy GABA-A Receptor Encephalitis after Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma: 3 cases and Literature Review , Neurology: Neuroimmunology & Neuroinflammation., 9(6): 2022,e200024


Hoshina Y, Galli J, Wong KH, Kovacsovics T, Steinbach M, Salzman KL, McNally JS, Lancaster E, Paz Soldán MM, Clardy SL. GABA-A Receptor Encephalitis After Autologous Hematopoietic Stem Cell Transplant forMultiple Myeloma: Three Cases and Literature Review. , Neurol Neuroimmunol Neuroinflamm. , 9(6): 2022,e200024


Adam M Kruszewski, Zujaja Tauqeer, Elana A Meer, Sana Ali Bautista, Neena R Cherayil, Marcus E Cimino, Sami L Khella, Eric Lancaster, Shawn J Bird, Steven S Scherer, Karen E Revere, Ali G Hamedani, Grant T Liu, Madhura A Tamhankar Vision Loss as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy: A Case Series , Journal of Neuroophthalmology: 2022